BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 27073063)

  • 1. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.
    AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Lemens MA; Stewart EA
    Am J Obstet Gynecol; 2016 Sep; 215(3):338.e1-338.e18. PubMed ID: 27073063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis.
    Barnard EP; AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Peterson LG; Stewart EA
    Am J Obstet Gynecol; 2017 May; 216(5):500.e1-500.e11. PubMed ID: 28063909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.
    Laughlin-Tommaso S; Barnard EP; AbdElmagied AM; Vaughan LE; Weaver AL; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Moriarty JP; Gorny KR; Leppert PC; Severson AL; Lemens MA; Stewart EA
    Am J Obstet Gynecol; 2019 Feb; 220(2):174.e1-174.e13. PubMed ID: 30696556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine and Fibroid Imaging Analysis from the FIRSTT Study.
    Laughlin-Tommaso SK; Gorny KR; Hesley GK; Vaughan LE; Woodrum DA; Lemens MA; Stewart EA
    J Womens Health (Larchmt); 2022 Apr; 31(4):546-554. PubMed ID: 34242085
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.
    de Bruijn AM; Ankum WM; Reekers JA; Birnie E; van der Kooij SM; Volkers NA; Hehenkamp WJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):745.e1-745.e12. PubMed ID: 27393268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound.
    Stovall DW
    Menopause; 2011 Apr; 18(4):437-44. PubMed ID: 21701430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trial.
    Bouwsma EV; Hesley GK; Woodrum DA; Weaver AL; Leppert PC; Peterson LG; Stewart EA
    Fertil Steril; 2011 Sep; 96(3):704-10. PubMed ID: 21794858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of medical, surgical and complementary treatments among women with fibroids.
    Jacoby VL; Jacoby A; Learman LA; Schembri M; Gregorich SE; Jackson R; Kuppermann M
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():220-5. PubMed ID: 25445104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroids treated with uterine artery embolization: do imaging findings correlate with patient outcomes?
    Millo N; Boroditsky R; Lyons EA
    J Obstet Gynaecol Can; 2010 May; 32(5):460-466. PubMed ID: 20500955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.
    Jacoby VL; Kohi MP; Poder L; Jacoby A; Lager J; Schembri M; Rieke V; Grady D; Vittinghoff E; Coakley FV
    Fertil Steril; 2016 Mar; 105(3):773-780. PubMed ID: 26658133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors.
    Mohr-Sasson A; Machtinger R; Mashiach R; Nir O; Inbar Y; Maliyanker N; Goldenberg M; Rabinovici J
    Am J Obstet Gynecol; 2018 Oct; 219(4):375.e1-375.e7. PubMed ID: 30217580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR Appropriateness Criteria® on treatment of uterine leiomyomas.
    Burke CT; Funaki BS; Ray CE; Kinney TB; Kostelic JK; Loesberg A; Lorenz JM; Millward SF; Nemcek AA; Owens CA; Shaw H; Silberzweig JE; Vatakencherry G
    J Am Coll Radiol; 2011 Apr; 8(4):228-34. PubMed ID: 21458760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAS position statement: management of uterine fibroids.
    Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
    Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.